EyeWorld China March 2019 Issue

2019年3月 61 EWAP ࢟଎ Ā뺯qāůĿǴċǢƢ˱ ፥᱾ڙ ԇࣕ *58 Ɨઍԇૼ뻟ŊĈşƍ ĈɝʚĀ뻟rŴĸ뻟̹ůĀǁԥă ѿǥ뻟ńăƢƆĄۚđࠬķĕ׮ ਮ͠뺯 ׼ǘŴ̹ů4GUVCUKUĀǁԥ뻟 ٔ ٯ ăĜ͔֚*58뻟&T *QNNCPF ĈƱķ뻟: K KFTCăĜĈɝʚ뺯Ƃ ǰĘ뻟:K KFTCĻĩĄ̀đπ☘Ɇ պٌ ߂ ସĀ*58ԇૼʼnĈČ̎뺯 ǢƢ☘ɆպٌĩѿLjȀ˱ ፥᱾ڙ ԇࣕĀƜ͔ɧٛ뻟ŴĶĜ̀đ̹ ůˍ˖ ۽ ˀ٩֑뻟&T *QN NCPF ̛ࣹė뻟ƍćĸĄۚ:KKFTCćы ဴȡ׼ΙȡԴ੾ସġĈ ߞ ̑ସग़ Āǟů뻟ńħĴĿɋ뺯 &T *QNNCPFşƍ:KKFTCŪβ ĀĂċȱਢĄđ͎՝ਮ͠뻟 ۽ ˀ ĻĩԪćࣟǟů뺯qਮ͠Ƃϵą ̛ĻĩĀࣟǟů뻟ŴĶĀѢˆď ăĜɏŦȏşŀŶƈĆǙǗƸĀ ਮ͠Ŧĭӷ˚뻟rŴĸ뺯Ă ݎ 뻟Ŵ ĜŠਮ͎͠ė͸ƴච༆뻟͎՝Ŵ ĶĻĩĜŜƍ͸ƴɝʚ뻟ؓƔĕ ƞǂ׳˄ăĠ뺯ǜƟ뻟Ĉ ߖ ͽŠ ɕεĀԇૼ뻟Ŵͱ͠Ĝźਮ͠ů ĉʕؐ઄શࣹ:KKFTC ۀ ɕ઄ͱ௴ Ȁᬎ୽ད৚뺯Ԛȏԇૼ뻟ĻĩĜ ӕů:K KFTCǴ̡뻟ƔŶ̹ůᬎ୽ ད৚ŶǞҬφ뺯 &T *QNNCPFģ͎՝ਮ͠뻟Ĉ Ăȏਮ̹͠ů ۀ ɕ઄ĜŜƍ̰ φ˸ˀ٣ચ뺯qĻĩĜ̰φևǥ ĂьĴǎ뻟rŴĸ뺯qāĶĻŘǞ ơ৭Ɉĉʕؐ઄뻟ȚĄƧư˸ƺ ăĩฎҫ뻟ਮ͠ăĜұ̰ǥʿ̹ ů ۽ ˀ뺯rਮ͠ăĩखɩǥʿĀ ˸ˀ٣ચ뻟ȚĄ˶̬ĀĄ뻟ĕ˄ ă˩Ȓ뻟&T *QNNCPF͎ė뺯Ţǘ :K KFTC˫ ە Āਮ͠뻟ŴȖɥźਮ ̹͠ů4GUVCUKU뺯 јǭ˄ą̛ਮ͠ħƇĭĜਮ ĈѝɕģʼnȶđuŴĶĄ͒ǘؐ ઄݀ఆńĄ᥿ ذ ფβĩă ݙ 뻟&T *QNNCPFĸ뺯qɈʏşƍʅşԇ뻟 Ϙϵ ܭ ਐԇȂ뻟rŴĸ뻟Ăȏֶŀ ŢǨĈĀѝɕਮ͠चůǜƟĀ ܭ ਐƶʒ뻟̣̹/)&ĈăǜĀ ܭ ਐƶޯ뺯qę י ĂͤĀਮ͠ĜԪ ćƪƞŪœ뻟ȚĄĆκ݉јǭĆ Џʬϵ ܭ ਐͬĂċ뻟rŴĸ뺯 ŢǘŦȏğőĎɏĄʅş ȡnjƟؐ઄݀ఆĀԇૼ뻟̹ů :K KFTCŶĜĈϑ ړ 뻟ȚĄঞƔĜ Ĉѝɕǂ׳뻟&T *QNNCPFӚ ڱ ȶ ĥӇଦ᥿ ذ ფҍ৑Ąۚ᥿ ذ ფĄ ŊĈņ פ Āɝʚ뺯Ƨưਮ͠ğő ĎɏĄʅşȡnjƟ઄݀ఆŠΜų /)&뻟&T *QNNCPFʙ˩Ĝźਮ ͠˱ћ̹ů:K KFTC뻟Ǟ௴Ȁ ͱ ƞ/)& ܭ ਐ뻟ҍ৑вư뺯 &T 2GT T [˓Ь뻟Ţǘኦੰȡ ѝɕԇૼ뻟 ܭ ਐǨĈԇȂʼnȶ đ뺯q ؽ ѷŢǘ ܭ ਐ᥿ ذ ფඑԇ ģʼnȶđ뻟ĻĩĜĈժཕͱѱ ٽ එԇĀŪœ뻟r&T 2GTT [ĸ뺯 qāΞħŖČđনз᥿ ذ ფ뻟ҍ ৑ȺŰ ߧ 뺯rǜƟ뻟ϿĠѝɕਮ͠ ĈdžׅĀ᥿ ذ ფସ뻟ˆ˽Šѝɕ ˄Ăő ܭ ਐ뻟&T 2GTT[Ҭφĸ뻟 ŴĂ ݎ Ĝনз᥿ ذ ფඑԇ뻟ƙׅ ųɕ᥿඙ᓴʓ פ ᥿ՙ뺯 q:K KFTCŠ4GUVCUK UĄ̛ј ƶʒ뻟ȚĄƧưĆăͩNjɕ᥿ ې ŀ뻟ƧưĆăͩNj ؽ ѷ뻟Ļĩ ĀժཕཕҔ뻟ଛ뻟ͱ͠ăʓࡼĄ ۚԪćѱ ٽ ɝʚૼƧЌဵૹᨘ ዅ뻟ĆďăĩʼnČŞħਮ͠˖ Ӫ뻟r&T 2GTT[ĸ뺯 & T *Q N N CPFĀҍž뻟ֶŀ ŮĄႊ ג ąŇˌœѝɕਮ͠뻟̞ ಗŦȏƧưӍĴႊ ג 뻟Ăũ˨ď ̹ů: K K F TCƦăĄϵ̹ůĂް Ⱥ̋ ۽ ˀǞũ˨̹ůĜĈъՎ Āਮ͠뺯qāΞħāĶˆ˽ćඑ ԇɋʿũ˨ႊ ג ѝɕ뻟ϗԭ̎ ȗԇȗϑȻ뻟Ɉʏ೤ ג එԇĀɘ ֐뻟r&T *QNNCPF ĸ뺯 EWAP 参考文献 1. Sheppard JD, et al. Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens. 2014;40:289–96. ່઎ۡ땻'U +ROODQGю6KLUH ϭӍ വ ݢ ๋զ ۮ 땾'U 3HUU\ю$OOHUJDQ ࢔%OHSK([ )UDQNOLQ 7HQQHVVHH ϭӍവ ݢ ๋զ ۮ 땾 联系方式 Holland: eholland@holprovision.com Perry: hankcornea@gmail.com